178 related articles for article (PubMed ID: 30115758)
1. Novel lncRNA
Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines.
Chen H; Libertini SJ; George M; Dandekar S; Tepper CG; Al-Bataina B; Kung HJ; Ghosh PM; Mudryj M
Endocr Relat Cancer; 2010 Dec; 17(4):857-73. PubMed ID: 20634343
[TBL] [Abstract][Full Text] [Related]
3.
Jillson LK; Rider LC; Rodrigues LU; Romero L; Karimpour-Fard A; Nieto C; Gillette C; Torkko K; Danis E; Smith EE; Nolley R; Peehl DM; Lucia MS; Costello JC; Cramer SD
Mol Cancer Res; 2021 Jul; 19(7):1123-1136. PubMed ID: 33846123
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus.
Sakurai K; Reon BJ; Anaya J; Dutta A
Mol Cancer Res; 2015 May; 13(5):828-38. PubMed ID: 25700553
[TBL] [Abstract][Full Text] [Related]
5. Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.
Paltoglou S; Das R; Townley SL; Hickey TE; Tarulli GA; Coutinho I; Fernandes R; Hanson AR; Denis I; Carroll JS; Dehm SM; Raj GV; Plymate SR; Tilley WD; Selth LA
Cancer Res; 2017 Jul; 77(13):3417-3430. PubMed ID: 28473532
[TBL] [Abstract][Full Text] [Related]
6. Identification of androgen response-related lncRNAs in prostate cancer.
Karthikeyan SK; Xu N; Ferguson Rd JE; Rais-Bahrami S; Qin ZS; Manne U; Netto GJ; S Chandrashekar D; Varambally S
Prostate; 2023 May; 83(6):590-601. PubMed ID: 36760203
[TBL] [Abstract][Full Text] [Related]
7. PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors.
Videira A; Beckedorff FC; daSilva LF; Verjovski-Almeida S
Cell Commun Signal; 2021 Jan; 19(1):5. PubMed ID: 33430890
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide RNA interference screen identifies new regulators of androgen receptor function in prostate cancer cells.
Imberg-Kazdan K; Ha S; Greenfield A; Poultney CS; Bonneau R; Logan SK; Garabedian MJ
Genome Res; 2013 Apr; 23(4):581-91. PubMed ID: 23403032
[TBL] [Abstract][Full Text] [Related]
9. Canonical and Nuclear mTOR Specify Distinct Transcriptional Programs in Androgen-Dependent Prostate Cancer Cells.
Chen Y; Han L; Dufour CR; Alfonso A; Giguère V
Mol Cancer Res; 2024 Feb; 22(2):113-124. PubMed ID: 37889103
[TBL] [Abstract][Full Text] [Related]
10. Revealing metastatic castration-resistant prostate cancer master regulator through lncRNAs-centered regulatory network.
Ferraz RS; Cavalcante JVF; Magalhães L; Ribeiro-Dos-Santos Â; Dalmolin RJS
Cancer Med; 2023 Sep; 12(18):19279-19290. PubMed ID: 37644825
[TBL] [Abstract][Full Text] [Related]
11. Cell- and gene-specific regulation of primary target genes by the androgen receptor.
Bolton EC; So AY; Chaivorapol C; Haqq CM; Li H; Yamamoto KR
Genes Dev; 2007 Aug; 21(16):2005-17. PubMed ID: 17699749
[TBL] [Abstract][Full Text] [Related]
12. A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer.
Warren AY; Massie CE; Watt K; Luko K; Orafidiya F; Selth LA; Mohammed H; Chohan BS; Menon S; Baridi A; Zhao W; Escriu C; Pungsrinont T; D'Santos C; Yang X; Taylor C; Qureshi A; Zecchini VR; Shaw GL; Dehm SM; Mills IG; Carroll JS; Tilley WD; McEwan IJ; Baniahmad A; Neal DE; Asim M
Oncogene; 2019 Feb; 38(7):1136-1150. PubMed ID: 30237440
[TBL] [Abstract][Full Text] [Related]
13. The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate Cancers.
Yao J; Chen Y; Nguyen DT; Thompson ZJ; Eroshkin AM; Nerlakanti N; Patel AK; Agarwal N; Teer JK; Dhillon J; Coppola D; Zhang J; Perera R; Kim Y; Mahajan K
Sci Rep; 2019 Jul; 9(1):9715. PubMed ID: 31273254
[TBL] [Abstract][Full Text] [Related]
14. Menin Enhances Androgen Receptor-Independent Proliferation and Migration of Prostate Cancer Cells.
Kim T; Jeong K; Kim E; Yoon K; Choi J; Park JH; Kim JH; Kim HS; Youn HD; Cho EJ
Mol Cells; 2022 Apr; 45(4):202-215. PubMed ID: 35014621
[TBL] [Abstract][Full Text] [Related]
15. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
Li ZF; Xiao N; Yao YW; Yao ZF
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
[TBL] [Abstract][Full Text] [Related]
16. ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells.
Komaragiri SK; Bostanthirige DH; Morton DJ; Patel D; Joshi J; Upadhyay S; Chaudhary J
Biochem Biophys Res Commun; 2016 Sep; 478(1):60-66. PubMed ID: 27462022
[TBL] [Abstract][Full Text] [Related]
17. Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.
Marques RB; Dits NF; Erkens-Schulze S; van Weerden WM; Jenster G
PLoS One; 2010 Oct; 5(10):e13500. PubMed ID: 20976069
[TBL] [Abstract][Full Text] [Related]
18. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis.
Massie CE; Lynch A; Ramos-Montoya A; Boren J; Stark R; Fazli L; Warren A; Scott H; Madhu B; Sharma N; Bon H; Zecchini V; Smith DM; Denicola GM; Mathews N; Osborne M; Hadfield J; Macarthur S; Adryan B; Lyons SK; Brindle KM; Griffiths J; Gleave ME; Rennie PS; Neal DE; Mills IG
EMBO J; 2011 May; 30(13):2719-33. PubMed ID: 21602788
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner.
Lee DY; Lee S; Kim YS; Park S; Bae SM; Cho EA; Park EJ; Park HH; Kim SY; So I; Chun JN; Jeon JH
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37888771
[TBL] [Abstract][Full Text] [Related]
20. Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers.
Ke Z; Hu X; Liu Y; Shen D; Khan MI; Xiao J
Crit Rev Oncol Hematol; 2024 Apr; 196():104275. PubMed ID: 38302050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
